drugset / Trial / NCT01470170

Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy

NCT01470170

Phase 4 Completed 173 enrolled Chang Gung Memorial Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Alfentanil (Alf) is used in combination with Propofol (Pro) in fiber-bronchoscopy and in many other conscious sedation procedures. Alf and Pro have the characteristic of rapid anesthetic onset and quick recovery, synergic sedative effect and unwanted side effects too. However, the amount of Alf needed in combination with Pro for induction and the timing of administration was no standardized. The investigators designed this study to evaluate the optimal regimen, dose and timing of Alf in Target-Controlled infusion (TCI) of Pro for flexible bronchoscopy sedation, and also to evaluate the influence of variable regimen of Alf and Pro on hypoxemia, hypotension, cough severity, and Pro injection related pain.

Timeline

Start
2010-10
Primary completion
2011-09
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfentanil Other / unclassified 2.5 ug/kg
Subject Alfentanil Other / unclassified 5 ug/kg
Subject Propofol Small molecule

Indications

No indication recorded.